Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II study of mature dendritic cell immunotherapy after resection of colorectal liver metastases
2008-007795-23Phase 2Terminated
- Sponsor
- Cima Universidad de Navarra
- Start
- Dec 2009
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of mature dendritic cells in metastatic colorectal adenocarcinoma (mCRC) and colorectal cancer (CRC) (2 arms), sponsored by Cima Universidad de Navarra. Primary endpoint: Progression-free survival. Started Dec 2009; status: terminated.
02
Drugs
mature dendritic cells
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2008-007795-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007795-23.